Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003643689 | SCV004413751 | pathogenic | Atrioventricular septal defect 4 | 2022-11-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with GATA4-related conditions. This sequence change creates a premature translational stop signal (p.Val218Glnfs*109) in the GATA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GATA4 are known to be pathogenic (PMID: 12845333, 15235040). This variant is not present in population databases (gnomAD no frequency). |